Lisinopril And Hydrochlorothiazide Tablet
Product Images NDC 68180-520

6 FDA label images from Lupin Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Lisinopril And Hydrochlorothiazide (NDC 68180-520). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (4035482a 7e09 464f Ae01 A8a75fc3c4c1 01)

Figure 1 (4035482a 7e09 464f Ae01 A8a75fc3c4c1 01)
Chemical structure diagram depicting the molecular formula of Lisinopril, including atoms, bonds, and hydration state with two water molecules indicated.*
FDA Label Image

Figure 2 (4035482a 7e09 464f Ae01 A8a75fc3c4c1 02)

Figure 2 (4035482a 7e09 464f Ae01 A8a75fc3c4c1 02)
Chemical structure diagram of Hydrochlorothiazide, showing the molecular arrangement including sulfonamide and chlorine functional groups.*
FDA Label Image

Image (4035482a 7e09 464f Ae01 A8a75fc3c4c1 145 1)

Image (4035482a 7e09 464f Ae01 A8a75fc3c4c1 145 1)
The image shows a white prescription drug bottle with a white cap. The label identifies the product as Lisinopril and Hydrochlorothiazide tablets, oral use. The label includes dosage information and usage directions, with the labeler listed as Lupin Pharmaceuticals, Inc. The bottle is typically used for dispensing tablets containing a combination of Lisinopril and Hydrochlorothiazide.*
FDA Label Image

Lis+hctz, 10-12.5-100s (4035482a 7e09 464f Ae01 A8a75fc3c4c1 03)

Lis+hctz, 10-12.5-100s (4035482a 7e09 464f Ae01 A8a75fc3c4c1 03)
Label for Lisinopril and Hydrochlorothiazide Tablets USP 10 mg/12.5 mg by Lupin Pharmaceuticals, Inc. Contains 100 tablets. The label includes storage instructions and notes usual adult dosage details are in the prescribing information. Manufactured by Lupin Limited in India, distributed by Lupin Pharmaceuticals, Naples, FL.*
FDA Label Image

Lis+hctz-20-12.5 mg (4035482a 7e09 464f Ae01 A8a75fc3c4c1 04)

Lis+hctz-20-12.5 mg (4035482a 7e09 464f Ae01 A8a75fc3c4c1 04)
Packaging label for Lisinopril and Hydrochlorothiazide Tablets USP, 20 mg/12.5 mg. The label shows the product as tablets, with a package count of 100 tablets. It is manufactured for Lupin Pharmaceuticals, Inc., Naples, FL, and produced by Lupin Limited in Nagpur, India. Storage instructions are included, along with a barcode and NDC 68180-519-01.*
FDA Label Image

Lis+hctz-20-25 mg (4035482a 7e09 464f Ae01 A8a75fc3c4c1 05)

Lis+hctz-20-25 mg (4035482a 7e09 464f Ae01 A8a75fc3c4c1 05)
Label for Lisinopril and Hydrochlorothiazide Tablets USP, 20 mg/25 mg strength. The label indicates each tablet contains 20 mg of Lisinopril and 25 mg of Hydrochlorothiazide. It is packaged as 100 tablets and labeled for prescription use only. Manufactured for Lupin Pharmaceuticals, Inc., with manufacturing by Lupin Limited in India. Storage instructions state controlled room temperature between 20° to 25°C (68° to 77°F).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.